Low apolipoprotein A-I levels in Friedreich's ataxia and in frataxin-deficient cells: Implications for therapy.
Friedreich's ataxia (FA) is an autosomal recessive neurodegenerative disorder, which results primarily from reduced expression of the mitochondrial protein frataxin. FA has an estimated prevalence of one in 50,000 in the population, making it the most common hereditary ataxia. Paradoxically, mo...
Main Authors: | QingQing Wang, Lili Guo, Cassandra J Strawser, Lauren A Hauser, Wei-Ting Hwang, Nathaniel W Snyder, David R Lynch, Clementina Mesaros, Ian A Blair |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2018-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5813973?pdf=render |
Similar Items
-
Simultaneous Quantification of Mitochondrial Mature Frataxin and Extra-Mitochondrial Frataxin Isoform E in Friedreich’s Ataxia Blood
by: Qingqing Wang, et al.
Published: (2022-04-01) -
DNA methylation in Friedreich ataxia silences expression of frataxin isoform E
by: Layne N. Rodden, et al.
Published: (2022-03-01) -
Human frataxin, the Friedreich ataxia deficient protein, interacts with mitochondrial respiratory chain
by: Davide Doni, et al.
Published: (2023-12-01) -
HDAC inhibitors correct frataxin deficiency in a Friedreich ataxia mouse model.
by: Myriam Rai, et al.
Published: (2008-01-01) -
Epigenetic modification of the frataxin gene for the treatment of Friedreich’s ataxia
by: Vilema Enriquez, MG
Published: (2018)